Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Duvelisib: a new phosphoinositide-3-kinase inhibitor in chronic lymphocytic leukemia.

Frustaci AM, Tedeschi A, Deodato M, Zamprogna G, Cairoli R, Montillo M.

Future Oncol. 2019 May 29. doi: 10.2217/fon-2018-0881. [Epub ahead of print]

PMID:
31137964
2.

Ibrutinib for the treatment of chronic lymphocytic leukemia.

Deodato M, Frustaci AM, Zamprogna G, Cairoli R, Montillo M, Tedeschi A.

Expert Rev Hematol. 2019 May;12(5):273-284. doi: 10.1080/17474086.2019.1597703. Epub 2019 Apr 11.

PMID:
30916599
3.

Prognostic Impact of Immunohistochemical p53 Expression in Bone Marrow Biopsy in Higher Risk MDS: a Pilot Study.

Molteni A, Ravano E, Riva M, Nichelatti M, Bandiera L, Crucitti L, Truini M, Cairoli R.

Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019015. doi: 10.4084/MJHID.2019.015. eCollection 2019.

4.

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia.

Alfonso V, Iaccarino L, Ottone T, Cicconi L, Lavorgna S, Divona M, Cairoli R, Cristiano A, Ciardi C, Travaglini S, Falconi G, Hasan SK, Venditti A, Arcese W, Voso MT, Lo-Coco F.

Leukemia. 2019 Jun;33(6):1527-1530. doi: 10.1038/s41375-018-0298-3. Epub 2019 Jan 16. No abstract available.

PMID:
30651632
5.

Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia.

Reda G, Riva M, Fattizzo B, Cassin R, Giannarelli D, Pennisi M, Freyrie A, Cairoli R, Molteni A, Cortelezzi A.

Semin Hematol. 2018 Oct;55(4):202-208. doi: 10.1053/j.seminhematol.2018.02.005. Epub 2018 Feb 21. Review.

PMID:
30502848
6.

Impact of serial echocardiography in the management of primary cardiac lymphoma.

Cereda AF, Moreo AM, Sormani P, De Chiara B, Casadei F, Zancanella M, Rusconi C, Cairoli R, Giannattasio C.

J Saudi Heart Assoc. 2018 Apr;30(2):160-163. doi: 10.1016/j.jsha.2017.08.001. Epub 2017 Aug 19. No abstract available.

7.

Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia.

Pungolino E, Rossi G, De Canal G, Trojani A, D'adda M, Perego A, Orlandi EM, Lunghi F, Turrini M, Borin L, Iurlo A, Latargia ML, Carraro MC, Spina F, Lodola M, Artale S, Anghilieri M, Spedini P, Cantoni S, Di Camillo B, Morra E, Cairoli R.

Am J Hematol. 2018 Jul;93(7):E162-E164. doi: 10.1002/ajh.25106. Epub 2018 May 17. No abstract available.

8.

Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Lazzarotto T, Chiereghin A, Piralla A, Piccirilli G, Girello A, Campanini G, Gabrielli L, Costa C, Prete A, Bonifazi F, Busca A, Cairoli R, Colombo AA, Zecca M, Sidoti F, Bianco G, Paba P, Perno CF, Cavallo R, Baldanti F; AMCLI-GLaIT working group.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1699-1706. doi: 10.1016/j.bbmt.2018.03.005. Epub 2018 Mar 12.

PMID:
29545186
9.

Waldenstrom's Macroglobulinemia: An Update.

Mazzucchelli M, Frustaci AM, Deodato M, Cairoli R, Tedeschi A.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018004. doi: 10.4084/MJHID.2018.004. eCollection 2018. Review.

10.

Ibrutinib and its use in the treatment of chronic lymphocytic leukemia.

Frustaci AM, Tedeschi A, Deodato M, Mazzucchelli M, Cairoli R, Montillo M.

Future Oncol. 2018 Apr;14(8):681-697. doi: 10.2217/fon-2017-0466. Epub 2017 Dec 15.

PMID:
29243946
11.

Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).

Borlenghi E, Pagani C, Zappasodi P, Bernardi M, Basilico C, Todisco E, Fracchiolla N, Mancini V, Turrini M, Da Vià M, Sala E, Cattaneo C, Petullà M, Serana F, Ferrario A, Cairoli R, Cortelezzi A, Santoro A, Castagnola C, Rossi G.

Am J Hematol. 2018 Feb;93(2):E54-E57. doi: 10.1002/ajh.24977. Epub 2017 Dec 4. No abstract available.

12.

Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment.

Trojani A, Pungolino E, Rossi G, D'Adda M, Lodola M, Camillo BD, Perego A, Turrini M, Orlandi E, Borin L, Iurlo A, Malato S, Spina F, Latargia ML, Lanza F, Artale S, Anghilieri M, Carraro MC, Canal G, Morra E, Cairoli R.

Cancer Biomark. 2017 Dec 12;21(1):41-53. doi: 10.3233/CBM-170209.

PMID:
29036785
13.

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Cantoni S, Carpenedo M, Mazzucconi MG, De Stefano V, Carrai V, Ruggeri M, Specchia G, Vianelli N, Pane F, Consoli U, Artoni A, Zaja F, D'adda M, Visentin A, Ferrara F, Barcellini W, Caramazza D, Baldacci E, Rossi E, Ricco A, Ciminello A, Rodeghiero F, Nichelatti M, Cairoli R.

Am J Hematol. 2018 Jan;93(1):58-64. doi: 10.1002/ajh.24935. Epub 2017 Nov 9.

14.

Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy).

Fracchiolla NS, Todisco E, Bilancia A, Gandolfi S, Orofino N, Guidotti F, Mancini V, Marbello L, Assanelli A, Bernardi M, Santoro A, Cairoli R, Consonni D, Cortelezzi A.

Am J Hematol. 2017 Dec;92(12):E656-E659. doi: 10.1002/ajh.24903. Epub 2017 Oct 10. No abstract available.

15.

Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports.

Grossi G, Viganò M, Facchetti F, Labanca S, Loglio A, Dodero A, Montefusco V, Corradini P, Cafro A, Cairoli R, Colombo M, Lampertico P.

Haematologica. 2017 Oct;102(10):e423-e426. doi: 10.3324/haematol.2017.168609. Epub 2017 Jun 28. No abstract available.

16.

Is HBV prophylaxis required during CLL treatment with ibrutinib?

Tedeschi A, Frustaci AM, Mazzucchelli M, Cairoli R, Montillo M.

Leuk Lymphoma. 2017 Dec;58(12):2966-2968. doi: 10.1080/10428194.2017.1317094. Epub 2017 May 23. No abstract available.

PMID:
28535112
17.

Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia.

Lazzaroni F, Giacco LD, Biasci D, Turrini M, Prosperi L, Brusamolino R, Cairoli R, Beghini A.

Sci Rep. 2017 Apr 26;7:46788. doi: 10.1038/srep46788. No abstract available.

18.

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry.

Pennisi M, Cesana C, Cittone MG, Bandiera L, Scarpati B, Mancini V, Soriani S, Veronese S, Truini M, Rossini S, Cairoli R.

Case Rep Hematol. 2017;2017:4984951. doi: 10.1155/2017/4984951. Epub 2017 Mar 20.

19.

Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.

Molteni A, Riva M, Ravano E, Marbello L, Mancini V, Grillo G, Zucchetti E, Greco R, Cairoli R.

Int J Hematol. 2017 Jun;105(6):769-776. doi: 10.1007/s12185-017-2198-0. Epub 2017 Feb 20.

PMID:
28220349
20.

Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia.

Lazzaroni F, Del Giacco L, Biasci D, Turrini M, Prosperi L, Brusamolino R, Cairoli R, Beghini A.

Sci Rep. 2016 Nov 17;6:37201. doi: 10.1038/srep37201. Erratum in: Sci Rep. 2017 Apr 26;7:46788.

21.

Clinical relevance of antiplatelet antibodies and the hepatic clearance of platelets in patients with immune thrombocytopenia.

Cantoni S, Carpenedo M, Nichelatti M, Sica L, Rossini S, Milella M, Popescu C, Cairoli R.

Blood. 2016 Oct 27;128(17):2183-2185. Epub 2016 Sep 6. No abstract available.

22.

Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association data.

Frustaci AM, Tedeschi A, Picardi P, Mazzucchelli M, Cairoli R, Montillo M.

Ther Adv Hematol. 2016 Aug;7(4):222-30. doi: 10.1177/2040620716648567. Epub 2016 May 21. Review.

23.

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F.

J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.

24.

Paving the way for new agents; is standard chemotherapy part of the treatment paradigm for chronic lymphocytic leukemia in the future?

Frustaci AM, Montillo M, Picardi P, Mazzucchelli M, Cairoli R, Tedeschi A.

Expert Rev Hematol. 2016 Jul;9(7):679-93. doi: 10.1080/17474086.2016.1191943. Epub 2016 Jun 8. Review.

PMID:
27253240
25.

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda".

Molteni A, Riva M, Borin L, Bernardi M, Pelizzari AM, Freyrie A, Della Porta M, Nichelatti M, Ravano E, Quaresmini G, Mariotti J, Caramazza D, Ubezio M, Guarco S, Gigli F, Greco R, Cairoli R, Morra E.

Leuk Res. 2016 Mar;42:21-7. doi: 10.1016/j.leukres.2016.01.006. Epub 2016 Jan 18.

PMID:
26852003
26.

Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.

Iaccarino L, Ottone T, Divona M, Cicconi L, Cairoli R, Voso MT, Lo-Coco F.

Br J Haematol. 2016 Mar;172(6):909-13. doi: 10.1111/bjh.13910. Epub 2016 Jan 5. Erratum in: Br J Haematol. 2016 Jul;174(2):335.

PMID:
26728337
27.

Response loss and development of neutralizing antibodies during long-term treatment with romiplostim in patients with immune thrombocytopenia: a case series.

Carpenedo M, Cantoni S, Coccini V, Pogliani EM, Cairoli R.

Eur J Haematol. 2016 Jul;97(1):101-103. doi: 10.1111/ejh.12733. Epub 2016 Feb 4.

PMID:
26718013
28.

Bing Neel Syndrome in a Previously Untreated Patient With Waldenström's Macroglobulinemia: Contribution of MYD88 L265P Mutation on Cerebrospinal Fluid.

Frustaci AM, Rusconi C, Picardi P, Veronese S, Montillo M, Cairoli R, Tedeschi A.

Clin Lymphoma Myeloma Leuk. 2016 Jan;16(1):e7-9. doi: 10.1016/j.clml.2015.11.004. Epub 2015 Dec 2. No abstract available.

PMID:
26705679
29.

Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles.

Bertani G, Santoleri L, Ferri U, Marenco P, Grillo G, Zucchetti E, Forno B, Lando G, Scarpati B, Cairoli R, Rossini S, Cesana C.

Transfusion. 2016 Feb;56(2):505-10. doi: 10.1111/trf.13369. Epub 2015 Oct 10.

PMID:
26453579
30.

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia.

Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M.

Biologics. 2015 Sep 18;9:75-86. doi: 10.2147/BTT.S60503. eCollection 2015. Review.

31.

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.

Tedeschi A, Rossi D, Motta M, Quaresmini G, Rossi M, Coscia M, Anastasia A, Rossini F, Cortelezzi A, Nador G, Scarfò L, Cairoli R, Frustaci AM, Dalceggio D, Picardi P, De Paoli L, Orlandi E, Rambaldi A, Massaia M, Gaidano G, Montillo M; Rete Ematologica Lombarda–CLL Workgroup.

Haematologica. 2015 Dec;100(12):e501-4. doi: 10.3324/haematol.2015.132035. Epub 2015 Aug 20. No abstract available.

32.

Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant.

Mangiacavalli S, Pochintesta L, Ravelli E, Baldini L, Ferretti VV, La Targia ML, Farina L, Cocito F, Cairoli R, Montefusco V, Corso A.

Leuk Lymphoma. 2015 Jun;56(6):1901-2. doi: 10.3109/10428194.2014.979414. Epub 2015 Jan 14. No abstract available.

PMID:
25347423
33.

Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes.

Molteni A, Riva M, Cesana C, Speziale V, Nichelatti M, Scarpati B, Greco R, Ravano E, Cairoli R, Rossini S, Morra E.

Eur J Haematol. 2015 Jun;94(6):519-25. doi: 10.1111/ejh.12465. Epub 2014 Dec 4.

PMID:
25307971
34.

Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.

Bertani G, Santoleri L, Martino M, Fedele R, Moscato T, Marenco P, Grillo G, Zucchetti E, Lotesoriere I, Lando G, Cesana C, Cairoli R, Rossini S.

Transfusion. 2014 Aug;54(8):2028-33. doi: 10.1111/trf.12612. Epub 2014 Mar 3.

PMID:
24588265
35.

Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?

Ricci F, Tedeschi A, Vismara E, Colombo C, Veronese S, Nichelatti M, Cairoli R, Morra E, Montillo M.

Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):441-6. doi: 10.1016/j.clml.2013.02.024. Epub 2013 Jun 14.

PMID:
23773451
36.

Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta.

Cairoli R, Beghini A, Turrini M, Bertani G, Nadali G, Rodeghiero F, Castagnola C, Lazzaroni F, Nichelatti M, Ferrara F, Pizzolo G, Pogliani E, Rossi G, Martinelli G, Morra E.

Am J Hematol. 2013 Jul;88(7):594-600. doi: 10.1002/ajh.23461. Epub 2013 Jun 5.

37.

Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells.

Beghini A, Corlazzoli F, Del Giacco L, Re M, Lazzaroni F, Brioschi M, Valentini G, Ferrazzi F, Ghilardi A, Righi M, Turrini M, Mignardi M, Cesana C, Bronte V, Nilsson M, Morra E, Cairoli R.

Neoplasia. 2012 Dec;14(12):1236-48.

38.

Prognostic markers in AML: focus on CBFL.

Cairoli R, Beghini A, Turrini M, Bertani G, Morra E.

Leuk Suppl. 2012 Aug;1(Suppl 2):S12-3. doi: 10.1038/leusup.2012.9. Epub 2012 Aug 9.

39.

A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Cristallo AF, Schroeder J, Citterio A, Santori G, Ferrioli GM, Rossi U, Bertani G, Cassano S, Gottardi P, Ceschini N, Barocci F, Ribizzi G, Cutrupi V, Cairoli R, Rapisarda V, Pastorello EA, Barocci S.

Int J Immunogenet. 2011 Aug;38(4):303-9. doi: 10.1111/j.1744-313X.2011.01011.x. Epub 2011 May 4.

PMID:
21545408
40.

Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome.

Cesana C, Klersy C, Scarpati B, Brando B, Faleri M, Bertani G, Gatti A, Volpato E, Barba C, Ferri U, Scampini L, Grillo G, Lando G, Nosari A, Morra E, Cairoli R.

Ann Hematol. 2011 Jul;90(7):827-35. doi: 10.1007/s00277-010-1145-4. Epub 2011 Jan 7.

PMID:
21212952
41.

Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Brioschi M, Fischer J, Cairoli R, Rossetti S, Pezzetti L, Nichelatti M, Turrini M, Corlazzoli F, Scarpati B, Morra E, Sacchi N, Beghini A.

Neoplasia. 2010 Nov;12(11):866-76.

42.

Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids.

Cesana C, Klersy C, Scarpati B, Brando B, Volpato E, Bertani G, Faleri M, Nosari A, Cantoni S, Ferri U, Scampini L, Barba C, Lando G, Morra E, Cairoli R.

Leuk Res. 2010 Aug;34(8):1027-34. doi: 10.1016/j.leukres.2010.02.008. Epub 2010 Mar 5.

PMID:
20206995
43.

Total serum tryptase: a predictive marker for KIT mutation in acute myeloid leukemia.

Cairoli R, Ripamonti CB, Beghini A, Granata S, Grillo G, Brioschi M, Nadali G, Viola A, Cattaneo C, Inropido L, Ravelli E, Bertani G, Pezzetti L, Nichelatti M, Marocchi A, Rossi G, Pizzolo G, Ferrara F, Nosari AM, Morra E.

Leuk Res. 2009 Sep;33(9):1282-4. doi: 10.1016/j.leukres.2009.03.043. Epub 2009 Apr 29.

PMID:
19406474
44.

Safety of recreational scuba diving in type 1 diabetic patients: the Deep Monitoring programme.

Bonomo M, Cairoli R, Verde G, Morelli L, Moreo A, Grottaglie MD, Brambilla MC, Meneghini E, Aghemo P, Corigliano G, Marroni A.

Diabetes Metab. 2009 Apr;35(2):101-7. doi: 10.1016/j.diabet.2008.08.007. Epub 2009 Feb 28.

PMID:
19251448
45.

Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation.

Trojani A, Ripamonti CB, Penco S, Beghini A, Nadali G, Di Bona E, Viola A, Castagnola C, Colapietro P, Grillo G, Pezzetti L, Ravelli E, Patrosso MC, Marocchi A, Cuneo A, Ferrara F, Lazzarino M, Pizzolo G, Cairoli R, Morra E.

Anticancer Res. 2008 Sep-Oct;28(5A):2745-51.

46.

Prognostic value of circulating CD34+ cells in myelodysplastic syndromes.

Cesana C, Klersy C, Brando B, Nosari A, Scarpati B, Scampini L, Molteni A, Nador G, Santoleri L, Formenti M, Valentini M, Mazzone A, Morra E, Cairoli R.

Leuk Res. 2008 Nov;32(11):1715-23. doi: 10.1016/j.leukres.2008.03.028. Epub 2008 May 5.

PMID:
18456323
47.

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.

Arcaini L, Montanari F, Alessandrino EP, Tucci A, Brusamolino E, Gargantini L, Cairoli R, Bernasconi P, Passamonti F, Bonfichi M, Zoli V, Bottelli C, Calatroni S, Troletti D, Merli M, Pascutto C, Majolino I, Rossi G, Morra E, Lazzarino M.

Ann Oncol. 2008 Jul;19(7):1331-5. doi: 10.1093/annonc/mdn044. Epub 2008 Mar 15.

PMID:
18344536
48.

Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years.

Corso A, Mangiacavalli S, Barbarano L, Alessandrino EP, Cairoli R, Morra E, Lazzarino M; HOST Group.

Cancer. 2007 Jun 1;109(11):2273-8.

49.

Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia.

Nosari A, Ravini M, Cairoli R, Cozzi P, Marbello L, Marenco P, Grillo G, Morra E.

Bone Marrow Transplant. 2007 May;39(10):631-5. Epub 2007 Mar 26.

PMID:
17384656
50.

Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens.

Nosari A, Cairoli R, Ciapanna D, Gargantini L, Intropido L, Baraté C, Scarpati B, Santoleri L, Nador G, Pezzetti L, Morra E.

Bone Marrow Transplant. 2006 Sep;38(6):413-6. Epub 2006 Jul 31.

PMID:
16878144

Supplemental Content

Loading ...
Support Center